Trogocytosis is specifically observed in HER2+ breast cancer cell lines and CD14+ cells exhibited a greater degree of trogocytosis than CD56+ cells in in vitro trogocytosis assays. This evidence concerns the gene NCAM1 and breast carcinoma.